- Home
- GSBC vs ABSI Comparison
GSBC vs ABSI Comparison
Compare GSBC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSBC | ABSI |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 859.1M | 997.8M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GSBC | ABSI |
|---|---|---|
| Price | $78.11 | $9.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $65.00 | $6.96 |
| AVG Volume (30 Days) | 61.6K | ★ 3.4M |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | ★ 17.68 | 10.64 |
| EPS | ★ 2.99 | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | $215.96 |
| Revenue Next Year | $2.56 | $319.10 |
| P/E Ratio | $26.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $53.76 | $2.24 |
| 52 Week High | $82.91 | $12.06 |
Technical Indicators
Market Signals| Indicator | GSBC | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.48 | N/A |
| Support Level | $77.24 | N/A |
| Resistance Level | $82.03 | N/A |
| Average True Range (ATR) | 1.28 | 0.00 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 8.18 | 0.00 |
Price Performance
Historical ComparisonAbout GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.